Literature DB >> 16828552

Synthesis and evaluation of 3-aminopropionyl substituted fentanyl analogues for opioid activity.

Ravil R Petrov1, Ruben S Vardanyan, Yeon S Lee, Shou-wu Ma, Peg Davis, Lucinda J Begay, Josephine Y Lai, Frank Porreca, Victor J Hruby.   

Abstract

An enkephalin analogue coupled to 'aminofentanyl' has been synthesized and tested for biological activities at the mu and delta opioid receptors. Aminofentanyl which represents a structural derivative of fentanyl has been synthesized by acylation of 1-(2-phenethyl)-4-(N-anilino)piperidine with phthaloyl protected beta-alaninyl chloride in the presence of DIPEA, followed by deprotection with hydrazine hydrate. Aminofentanyl has also been successfully acylated with ethyl isocyanate, various acid anhydrides, to further investigate structure-activity relationships of these new fentanyl derivatives. Among the new derivatives compound 7 which carries a Tyr-D-Ala-Gly-Phe opioid message sequence showed good opioid affinity (1 nM at both delta and mu opioid receptors) and bioactivity (34.9 nM in MVD and 42 nM in GPI/LMMP bioassays).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16828552      PMCID: PMC1783977          DOI: 10.1016/j.bmcl.2006.06.040

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  21 in total

1.  RTI-4614-4: an analog of (+)-cis-3-methylfentanyl with a 27,000-fold binding selectivity for mu versus delta opioid binding sites.

Authors:  R B Rothman; H Xu; M Seggel; A E Jacobson; K C Rice; G A Brine; F I Carroll
Journal:  Life Sci       Date:  1991       Impact factor: 5.037

2.  Comparative binding of mu and delta selective ligands in whole brain and pons/medulla homogenates from rat: affinity profiles of fentanyl derivatives.

Authors:  M Yeadon; I Kitchen
Journal:  Neuropharmacology       Date:  1988-04       Impact factor: 5.250

3.  In vitro potency, affinity and agonist efficacy of highly selective delta opioid receptor ligands.

Authors:  T H Kramer; P Davis; V J Hruby; T F Burks; F Porreca
Journal:  J Pharmacol Exp Ther       Date:  1993-08       Impact factor: 4.030

4.  Synthesis and pharmacological evaluation of a series of new 3-methyl-1,4-disubstituted-piperidine analgesics.

Authors:  N Lalinde; J Moliterni; D Wright; H K Spencer; M H Ossipov; T C Spaulding; F G Rudo
Journal:  J Med Chem       Date:  1990-10       Impact factor: 7.446

5.  Dermorphin analogues carrying an increased positive net charge in their "message" domain display extremely high mu opioid receptor selectivity.

Authors:  P W Schiller; T M Nguyen; N N Chung; C Lemieux
Journal:  J Med Chem       Date:  1989-03       Impact factor: 7.446

6.  New 4-(heteroanilido)piperidines, structurally related to the pure opioid agonist fentanyl, with agonist and/or antagonist properties.

Authors:  J R Bagley; R L Wynn; F G Rudo; B M Doorley; H K Spencer; T Spaulding
Journal:  J Med Chem       Date:  1989-03       Impact factor: 7.446

7.  Guanidinium and aminoimidazolinium derivatives of N-(4-piperidyl)propanamides as potential ligands for mu opioid and I2-imidazoline receptors: synthesis and pharmacological screening.

Authors:  Ana Montero; Pilar Goya; Nadine Jagerovic; Luis F Callado; J Javier Meana; Rocío Girón; Carlos Goicoechea; Ma Isabel Martín
Journal:  Bioorg Med Chem       Date:  2002-04       Impact factor: 3.641

8.  Potential affinity labels for the opiate receptor based on fentanyl and related compounds.

Authors:  B E Maryanoff; E J Simon; T Gioannini; H Gorissen
Journal:  J Med Chem       Date:  1982-08       Impact factor: 7.446

Review 9.  Adverse effects of opioid agonists and agonist-antagonists in anaesthesia.

Authors:  T A Bowdle
Journal:  Drug Saf       Date:  1998-09       Impact factor: 5.606

10.  Conversion of delta-, kappa- and mu-receptor selective opioid peptide agonists into delta-, kappa- and mu-selective antagonists.

Authors:  Peter W Schiller; Grazyna Weltrowska; Thi M-D Nguyen; Carole Lemieux; Nga N Chung; Yixin Lu
Journal:  Life Sci       Date:  2003-06-27       Impact factor: 5.037

View more
  13 in total

1.  Design synthesis and structure-activity relationship of 5-substituted (tetrahydronaphthalen-2yl)methyl with N-phenyl-N-(piperidin-2-yl)propionamide derivatives as opioid ligands.

Authors:  Srinivas Deekonda; David Rankin; Peg Davis; Josephine Lai; Todd W Vanderah; Frank Porecca; Victor J Hruby
Journal:  Bioorg Med Chem       Date:  2015-11-23       Impact factor: 3.641

2.  Understanding the structural requirements of 4-anilidopiperidine analogues for biological activities at mu and delta opioid receptors.

Authors:  Yeon Sun Lee; Joel Nyberg; Sharif Moye; Richard S Agnes; Peg Davis; Shou-wu Ma; Josephine Lai; Frank Porreca; Ruben Vardanyan; Victor J Hruby
Journal:  Bioorg Med Chem Lett       Date:  2007-02-08       Impact factor: 2.823

Review 3.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

Review 4.  Fentanyl-related compounds and derivatives: current status and future prospects for pharmaceutical applications.

Authors:  Ruben S Vardanyan; Victor J Hruby
Journal:  Future Med Chem       Date:  2014-03       Impact factor: 3.808

5.  Discovery of 5-substituted tetrahydronaphthalen-2yl-methyl with N-phenyl-N-(piperidin-4-yl)propionamide derivatives as potent opioid receptor ligands.

Authors:  Srinivas Deekonda; Lauren Wugalter; Vinod Kulkarni; David Rankin; Tally M Largent-Milnes; Peg Davis; Neemah M Bassirirad; Josephine Lai; Todd W Vanderah; Frank Porreca; Victor J Hruby
Journal:  Bioorg Med Chem       Date:  2015-08-04       Impact factor: 3.641

6.  Effect of anchoring 4-anilidopiperidines to opioid peptides.

Authors:  Ravil R Petrov; Yeon Sun Lee; Ruben S Vardanyan; Lu Liu; Shou-wu Ma; Peg Davis; Josephine Lai; Frank Porreca; Todd W Vanderah; Victor J Hruby
Journal:  Bioorg Med Chem Lett       Date:  2013-04-03       Impact factor: 2.823

7.  Proton sharing and transfer in some zwitterionic compounds based on 4-oxo-4-((1-phenethylpiperidin-4-yl)(phenyl)amino)alcanoic acids.

Authors:  Gary S Nichol; Vlad K Kumirov; Ruben Vardanyan; Victor J Hruby
Journal:  CrystEngComm       Date:  2010       Impact factor: 3.545

8.  Enkephalin analogues with N-phenyl-N-(piperidin-2-ylmethyl)propionamide derivatives: Synthesis and biological evaluations.

Authors:  Srinivas Deekonda; Jacob Cole; Sydney Sunna; David Rankin; Tally M Largent-Milnes; Peg Davis; Neemah M BassiriRad; Josephine Lai; Todd W Vanderah; Frank Porecca; Victor J Hruby
Journal:  Bioorg Med Chem Lett       Date:  2015-11-03       Impact factor: 2.823

9.  Design and synthesis of novel bivalent ligands (MOR and DOR) by conjugation of enkephalin analogues with 4-anilidopiperidine derivatives.

Authors:  Srinivas Deekonda; Lauren Wugalter; David Rankin; Tally M Largent-Milnes; Peg Davis; Yue Wang; Neemah M Bassirirad; Josephine Lai; Vinod Kulkarni; Todd W Vanderah; Frank Porreca; Victor J Hruby
Journal:  Bioorg Med Chem Lett       Date:  2015-07-29       Impact factor: 2.823

10.  Development of novel enkephalin analogues that have enhanced opioid activities at both mu and delta opioid receptors.

Authors:  Yeon Sun Lee; Ravil Petrov; Chad K Park; Shou-wu Ma; Peg Davis; Josephine Lai; Frank Porreca; Ruben Vardanyan; Victor J Hruby
Journal:  J Med Chem       Date:  2007-10-10       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.